Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 251

Results For "PLI"

2778 News Found

Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Health minister Mandaviya launches i-Drone for vaccine delivery
Public Health | October 05, 2021

Health minister Mandaviya launches i-Drone for vaccine delivery

This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines


Zuellig Pharma receives EcoVadis Platinum medal for sustainability
Sustainability | October 05, 2021

Zuellig Pharma receives EcoVadis Platinum medal for sustainability

The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme


DentalMonitoring launches ScanBox, an AI-powered orthodontic care device
Medical Device | October 05, 2021

DentalMonitoring launches ScanBox, an AI-powered orthodontic care device

DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox


Amber Implants VCFix spinal system receives breakthrough designation
Healthcare | October 05, 2021

Amber Implants VCFix spinal system receives breakthrough designation

The first clinical trial is expected to commence in early 2022 both in Europe and the US


Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
Biotech | October 01, 2021

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA

The company plans to submit the IND application by the end of 2021


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021


Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
Biotech | October 01, 2021

Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy

Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval


Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


WHO new Essential Medicines Lists focus on diabetes and cancer
Public Health | September 30, 2021

WHO new Essential Medicines Lists focus on diabetes and cancer

The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all